Black Rock Inc. Altamira Therapeutics Ltd. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.48 - $1.66 $29,569 - $102,260
-61,603 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$0.69 - $1.92 $19,424 - $54,049
28,151 Added 84.15%
61,603 $67,000
Q4 2021

Feb 10, 2022
BUY
$1.28 - $2.4 $1,100 - $2,064
860 Added 2.64%
33,452 $61,000
Q3 2021

Nov 09, 2021
BUY
$2.01 - $3.58 $65,509 - $116,679
32,592 New
32,592 $65,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $475K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email